Interim Guidelines for the Evaluation and Testing of Infants with Possible Congenital Zika Virus Infection
The CDC has developed,
in consultation with the American Academy of Pediatrics, interim guidance for
the evaluation, testing, and management of infants born to mothers who traveled
to or resided in an area with Zika virus transmission during pregnancy. The
document provides guidance to healthcare providers caring for 1) infants with
microcephaly or intracranial calcifications detected prenatally or at birth or
2) infants without these findings whose risk is based on maternal exposure and
testing for Zika virus infection.
Briefly,
pediatric healthcare providers should ask mothers of newborns with microcephaly
or intracranial calcifications about their residence and travel while pregnant
as well as symptoms of illness compatible with Zika virus disease (acute onset
of fever, maculopapular rash, arthralgia, and conjunctivitis). In addition,
results of any Zika virus testing performed prior to delivery should be
obtained. Interim guidance includes consideration of clinical issues that
might be encountered in caring for infants who might have been infected with
Zika virus infection. Certain actions (e.g., cranial ultrasound and
ophthalmologic examination) are recommended for all infants being tested for
Zika virus infection, and other actions (e.g., repeat hearing screening,
developmental monitoring) are recommended for all infants with Zika virus
infection, regardless of the presence or absence of symptoms.
Interim Guidelines
for the Evaluation and Testing of Infants with Possible Congenital Zika Virus
Infection — United States, 2016
Early Release / January 26,
2016 / 65(3);1–5
http://www.cdc.gov/mmwr/volumes/65/wr/mm6503e3er.htm?s_cid=mm6503e3er.htm_w
For More Information